Jiang, H., Zhu, Y., Zhou, Z., Xu, J., Jin, S., Xu, K., . . . Xu, J. (2018). PRMT5 promotes cell proliferation by inhibiting BTG2 expression via the ERK signaling pathway in hepatocellular carcinoma. Cancer Med.
Citación estilo ChicagoJiang, Hai, et al. "PRMT5 Promotes Cell Proliferation By Inhibiting BTG2 Expression Via the ERK Signaling Pathway in Hepatocellular Carcinoma." Cancer Med 2018.
Cita MLAJiang, Hai, et al. "PRMT5 Promotes Cell Proliferation By Inhibiting BTG2 Expression Via the ERK Signaling Pathway in Hepatocellular Carcinoma." Cancer Med 2018.
Precaución: Estas citas no son 100% exactas.